Search
for
Sort by
Research 30 of 1000+
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Dermatological Adverse Effects of Covid-19 Vaccine among Healthcare Workers: Findings from a Tertiary Care Hospital in Northern India
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Dermatologic adverse effect of subcutaneous furosemide administration in a cat
- Dermatological adverse events with taxane chemotherapy
- ASSESSMENT OF SOCIODEMOGRAPHIC CHARACTERISTICS AND COMPARATIVE ANALYSIS OF ADVERSE DRUG REACTIONS AMONG OROPHARYNGEAL CANCER PATIENTS RECEIVING DIFFERENT CHEMOTHERAPEUTIC REGIMENS IN KARACHI, SINDH, PAKISTAN
- A Prospective Observational Study for Assessment of Chemotherapy-Induced Adverse Drug Reactions in Cancer Patients
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatological manifestations of COVID-19 and its therapies: a review
- Adverse Effects and Drug Interactions of Biologic Agents
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Study on prevalence, diagnosis and treatment of dermatological disorders in hospitalized dogs at Madras Veterinary College (MVC), Chennai, India
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Carbamazepine-Induced Hair Loss
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Adverse cutaneous effects of psychotropic medications
- Dermatologic Adverse Events from Cancer Treatments
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Adverse Cutaneous Reactions to Antidepressants
- Supportive Oncodermatology: Addressing dermatologic adverse events associated with oncologic therapies
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study